Intuitive Surgical, Inc. Proceeds from (Payments for) Other Financing Activities
Intuitive Surgical, Inc. (ISRG) reported Proceeds from (Payments for) Other Financing Activities of -$19.20 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-10-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2021-10-20
- Intuitive Surgical, Inc. proceeds from (payments for) other financing activities for the quarter ending 2021-09-30 was -$9.50M.
- Intuitive Surgical, Inc. proceeds from (payments for) other financing activities for the quarter ending 2021-06-30 was -$1.80M.
- Intuitive Surgical, Inc. proceeds from (payments for) other financing activities for the quarter ending 2021-03-31 was -$7.90M.
- Intuitive Surgical, Inc. proceeds from (payments for) other financing activities for the quarter ending 2020-09-30 was -$18.50M.
- Intuitive Surgical, Inc. proceeds from (payments for) other financing activities for fiscal 2018 was $9.70M, a 385.00% increase from fiscal 2017.
- Intuitive Surgical, Inc. proceeds from (payments for) other financing activities for fiscal 2017 was $2.00M.
- Intuitive Surgical, Inc. proceeds from (payments for) other financing activities for fiscal 2016 was $0.00.
- Intuitive Surgical, Inc. proceeds from (payments for) other financing activities for fiscal 2015 was -$7.30M.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 3 month as first filed | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 6 month as first filed | Proceeds from (Payments for) Other Financing Activities 9 month | Proceeds from (Payments for) Other Financing Activities 9 month as first filed | Proceeds from (Payments for) Other Financing Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2021-09-30 | -$9.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | -$11.30M derived: sum of 2 quarters · filed 2021-10-20 | -$19.20M 10-Q · filed 2021-10-20 | ||||
| 2021-06-30 | -$1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-21 | -$9.70M 10-Q · filed 2021-07-21 | |||||
| 2021-03-31 | -$7.90M 10-Q · filed 2021-04-21 | ||||||
| 2020-09-30 | -$18.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | -$27.40M derived: sum of 2 quarters · filed 2021-10-20 | -$48.50M 10-Q · filed 2021-10-20 | ||||
| 2020-06-30 | -$8.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-21 | -$30.00M 10-Q · filed 2021-07-21 | |||||
| 2020-03-31 | -$21.10M 10-Q · filed 2021-04-21 | ||||||
| 2019-09-30 | -$7.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-19 | -$10.50M derived: sum of 2 quarters · filed 2020-10-19 | -$12.50M 10-Q · filed 2020-10-19 | -$2.80M derived: sum of 4 quarters · filed 2020-10-19 | |||
| 2019-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | -$5.00M 10-Q · filed 2020-07-23 | $4.70M derived: sum of 3 quarters · filed 2020-07-23 | $4.70M derived: sum of 4 quarters · filed 2020-07-23 | |||
| 2019-03-31 | -$2.00M 10-Q · filed 2020-04-17 | $7.70M derived: sum of 2 quarters · filed 2020-04-17 | $7.70M derived: sum of 3 quarters · filed 2020-04-17 | $7.70M derived: sum of 4 quarters · filed 2020-04-17 | |||
| 2018-12-31 | $9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | $9.70M derived: sum of 2 quarters · filed 2019-10-18 | $9.70M derived: sum of 3 quarters · filed 2019-10-18 | $9.70M 10-K · filed 2019-02-04 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-18 | $0.00 derived: sum of 2 quarters · filed 2019-10-18 | $0.00 10-Q · filed 2019-10-18 | $8.00M 10-Q · filed 2018-10-22 | $0.00 derived: sum of 4 quarters · filed 2019-10-18 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-22 | $0.00 10-Q · filed 2019-07-22 | $8.00M 10-Q · filed 2018-07-20 | $0.00 derived: sum of 3 quarters · filed 2019-07-22 | $2.00M derived: sum of 4 quarters · filed 2019-07-22 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-04-19 | $8.00M 10-Q · filed 2018-04-18 | $0.00 derived: sum of 2 quarters · filed 2019-04-19 | $2.00M derived: sum of 3 quarters · filed 2019-04-19 | $2.00M derived: sum of 4 quarters · filed 2019-04-19 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | $2.00M derived: sum of 2 quarters · filed 2019-02-04 | $2.00M derived: sum of 3 quarters · filed 2019-02-04 | $2.00M 10-K · filed 2019-02-04 | |||
| 2017-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-22 | $2.00M derived: sum of 2 quarters · filed 2018-10-22 | $2.00M 10-Q · filed 2018-10-22 | $2.00M derived: sum of 4 quarters · filed 2019-02-04 | |||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-20 | $0.00 10-Q · filed 2018-07-20 | $0.00 derived: sum of 3 quarters · filed 2019-02-04 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2018-04-18 | $0.00 derived: sum of 2 quarters · filed 2019-02-04 | |||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | $0.00 10-K · filed 2019-02-04 | |||||
| 2016-09-30 | $0.00 10-Q · filed 2017-10-20 | ||||||
| 2015-12-31 | -$7.30M 10-K · filed 2018-02-02 | ||||||
| 2014-12-31 | $0.00 10-K · filed 2017-02-06 | ||||||
| 2013-12-31 | $0.00 10-K · filed 2016-02-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |